"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
| Descriptor ID |
D003362
|
| MeSH Number(s) |
N03.219.151.125
|
| Concept/Terms |
Cost-Benefit Analysis- Cost-Benefit Analysis
- Analyses, Cost-Benefit
- Analysis, Cost-Benefit
- Cost-Benefit Analyses
- Cost Benefit Analysis
- Analyses, Cost Benefit
- Analysis, Cost Benefit
- Cost Benefit Analyses
Cost-Utility Analysis- Cost-Utility Analysis
- Analyses, Cost-Utility
- Analysis, Cost-Utility
- Cost Utility Analysis
- Cost-Utility Analyses
Economic Evaluation- Economic Evaluation
- Economic Evaluations
- Evaluation, Economic
- Evaluations, Economic
Marginal Analysis- Marginal Analysis
- Analyses, Marginal
- Analysis, Marginal
- Marginal Analyses
Cost Benefit- Cost Benefit
- Costs and Benefits
- Benefits and Costs
|
Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".
Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".
This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in this website by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 10 | 11 |
| 1996 | 3 | 5 | 8 |
| 1997 | 4 | 11 | 15 |
| 1998 | 4 | 12 | 16 |
| 1999 | 1 | 15 | 16 |
| 2000 | 0 | 13 | 13 |
| 2001 | 0 | 6 | 6 |
| 2002 | 0 | 3 | 3 |
| 2003 | 1 | 6 | 7 |
| 2004 | 0 | 12 | 12 |
| 2005 | 0 | 8 | 8 |
| 2006 | 2 | 7 | 9 |
| 2007 | 0 | 11 | 11 |
| 2008 | 2 | 14 | 16 |
| 2009 | 0 | 20 | 20 |
| 2010 | 1 | 10 | 11 |
| 2011 | 1 | 14 | 15 |
| 2012 | 0 | 23 | 23 |
| 2013 | 1 | 14 | 15 |
| 2014 | 1 | 18 | 19 |
| 2015 | 1 | 15 | 16 |
| 2016 | 3 | 9 | 12 |
| 2017 | 9 | 14 | 23 |
| 2018 | 2 | 10 | 12 |
| 2019 | 3 | 7 | 10 |
| 2020 | 2 | 9 | 11 |
| 2021 | 1 | 8 | 9 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles.
-
Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program. Popul Health Manag. 2023 02; 26(1):72-82.
-
Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations. Pharmacoeconomics. 2023 Apr; 41(4):395-411.
-
Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 02; 8(8):777-785.
-
Estimated Monetary Value of Future Research Clarifying Uncertainties Around the Optimal Adult Hearing Screening Schedule. JAMA Health Forum. 2022 Nov 04; 3(11):e224065.
-
Model-Projected Cost-Effectiveness of Adult Hearing Screening in the USA. J Gen Intern Med. 2023 Mar; 38(4):978-985.
-
Letter from the Editor: Cost-effectiveness of tuberculosis screening in patients already on biologic therapy. J Am Acad Dermatol. 2022 10; 87(4):747-748.
-
How cost-effective is nutrition care delivered in primary healthcare settings? A systematic review of trial-based economic evaluations. Nutr Rev. 2022 05 09; 80(6):1480-1496.
-
A data driven policy to minimise the tuberculosis testing cost among healthcare workers. Int J Health Plann Manage. 2022 Sep; 37(5):2697-2709.
-
The Cost-Effectiveness of Nicotine Replacement Therapy Sampling in Primary Care: a Markov Cohort Simulation Model. J Gen Intern Med. 2022 11; 37(14):3684-3691.
-
A Cost-Effectiveness Analysis of Post-Void Residual Bladder Scan Thresholds in the Postoperative Setting. Int Urogynecol J. 2022 10; 33(10):2727-2733.